325 related articles for article (PubMed ID: 22167349)
1. Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.
Chang J; Paillard A; Passirani C; Morille M; Benoit JP; Betbeder D; Garcion E
Pharm Res; 2012 Jun; 29(6):1495-505. PubMed ID: 22167349
[TBL] [Abstract][Full Text] [Related]
2. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier.
Chang J; Jallouli Y; Kroubi M; Yuan XB; Feng W; Kang CS; Pu PY; Betbeder D
Int J Pharm; 2009 Sep; 379(2):285-92. PubMed ID: 19416749
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of nano-PTX to the brain tumor-associated macrophages.
Zou L; Tao Y; Payne G; Do L; Thomas T; Rodriguez J; Dou H
Oncotarget; 2017 Jan; 8(4):6564-6578. PubMed ID: 28036254
[TBL] [Abstract][Full Text] [Related]
4. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
Mao J; Meng X; Zhao C; Yang Y; Liu G
Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days.
Navarro SM; Darensbourg C; Cross L; Stout R; Coulon D; Astete CE; Morgan T; Sabliov CM
Ther Deliv; 2014 Nov; 5(11):1191-201. PubMed ID: 25491670
[TBL] [Abstract][Full Text] [Related]
6. Polysorbate 80-coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain-protective effects in rats.
Sun D; Xue A; Zhang B; Lou H; Shi H; Zhang X
J Pharm Pharmacol; 2015 Dec; 67(12):1650-62. PubMed ID: 26407669
[TBL] [Abstract][Full Text] [Related]
7. Transferrin-modified nanoparticles for targeted delivery of Asiatic acid to glioblastoma cells.
Ramalho MJ; Bravo M; Loureiro JA; Lima J; Pereira MC
Life Sci; 2022 May; 296():120435. PubMed ID: 35247437
[TBL] [Abstract][Full Text] [Related]
8. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.
Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729
[TBL] [Abstract][Full Text] [Related]
9. Comparative receptor based brain delivery of tramadol-loaded poly(lactic-co-glycolic acid) nanoparticles.
Lalani J; Raichandani Y; Mathur R; Lalan M; Chutani K; Mishra AK; Misra A
J Biomed Nanotechnol; 2012 Dec; 8(6):918-27. PubMed ID: 23030000
[TBL] [Abstract][Full Text] [Related]
10. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.
Ling Y; Wei K; Zou F; Zhong S
Int J Pharm; 2012 Jul; 430(1-2):266-75. PubMed ID: 22486964
[TBL] [Abstract][Full Text] [Related]
11. Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging.
Park J; Pei Y; Hyun H; Castanares MA; Collins DS; Yeo Y
J Control Release; 2017 Dec; 268():407-415. PubMed ID: 29111150
[TBL] [Abstract][Full Text] [Related]
12. Magnetic targeting of paclitaxel-loaded poly(lactic-
Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V
Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603
[TBL] [Abstract][Full Text] [Related]
13. Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood-brain barrier.
Chaturvedi M; Molino Y; Sreedhar B; Khrestchatisky M; Kaczmarek L
Int J Nanomedicine; 2014; 9():575-88. PubMed ID: 24531257
[TBL] [Abstract][Full Text] [Related]
14. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model.
Shah N; Chaudhari K; Dantuluri P; Murthy RS; Das S
J Drug Target; 2009 Aug; 17(7):533-42. PubMed ID: 19530913
[TBL] [Abstract][Full Text] [Related]
16. Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment.
Ramalho MJ; Sevin E; Gosselet F; Lima J; Coelho MAN; Loureiro JA; Pereira MC
Int J Pharm; 2018 Jul; 545(1-2):84-92. PubMed ID: 29715532
[TBL] [Abstract][Full Text] [Related]
17. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.
Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH
Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909
[TBL] [Abstract][Full Text] [Related]
18. Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Lin PI; Wang CC
Nanomedicine (Lond); 2011 Aug; 6(6):1011-26. PubMed ID: 21707298
[TBL] [Abstract][Full Text] [Related]
19. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency.
Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ
J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112
[TBL] [Abstract][Full Text] [Related]
20. Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7alpha-APTADD to breast cancer cells.
Zheng Y; Yu B; Weecharangsan W; Piao L; Darby M; Mao Y; Koynova R; Yang X; Li H; Xu S; Lee LJ; Sugimoto Y; Brueggemeier RW; Lee RJ
Int J Pharm; 2010 May; 390(2):234-41. PubMed ID: 20156537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]